
IPH5201
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
IPH5201 is a human IgG1 monoclonal antibody (mAb) targeting ENTPD1/CD39. IPH5201 accumulates immunostimulatory ATP released by tumor cells treated with combination chemotherapy (CT) and reduces immunosuppressive Ado levels in the tumor microenvironment (TME). IPH5201 can be used in anti-tumor immunity research. Recommended isotype control: Human IgG1 kappa, Isotype Control.
12352203
NTPDase
Immunology/Inflammation
Cancer-programmed cell death
Cancer
I[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5].[PH5]
[1]Barlesi F, et al. 1290TiP A phase II multicenter, open label, non-randomized study of neoadjuvant and adjuvant treatment with IPH5201 and durvalumab in patients with resectable, early-stage (II to IIIA) non-small cell lung cancer (MATISSE) [J]. Annals of Oncology, 2023, 34: S744.
Room temperature
http://file.medchemexpress.com/batch_PDF/HY-P991444/
Inhibitory Antibodies
No Development Reported
Beschrijving
IPH5201 is a human IgG1 monoclonal antibody (mAb) targeting ENTPD1/CD39. IPH5201 accumulates immunostimulatory ATP released by tumor cells treated with combinat
Specificaties
Recent bekeken producten

Human Mast Cells - Dermis
ABC-TC105W
1 Vial

CYP1A2 Inhibitor Screening Assay
MA-0389
200 Well

Culture Medium for Immortalized Human Parathyroid Cells
AFG-ELL-2645-01
100 mL

Immortalized Human Parathyroid Cells
AFG-ELL-2055
> 1x 10^6 Cells / Vial

1,4- Dioxane Pure
1041330 500
500 mL

EPS8 Antibody (N-term) [APR32555G]
APR32555G-01
50 µL

Prestained Protein Ladder (25-300 kDa)
CRG1114
250 µL

Rat IgG Lyophilized
B2013903
25 mg
Recent gezochte producten

Hsa-miR-1258 mimic
HY-R00162-01
5 nmol

Hsa-miR-4258 mimic
HY-R00937-01
5 nmol

hsa-miR-1258 miRNA Mimic
MBS8298831-01
5 nmol

hsa-miR-4258 miRNA Mimic
MBS8299087-01
5 nmol

hsa-miR-1258 miRNA Agomir
MBS8311479-01
5 nmol

Hsa-miR-1258 miRNA Mimic
CMH0784-01
5 nmol

Hsa-miR-4258 miRNA Mimic
CMH1040-01
5 nmol

Hsa-miR-4258 miRNA Agomir
CMJ1040-01
5 nmol
